Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
Go back to Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306| DaVita Inc. (NYSE: DVA) | Delayed: 208.66 +4.83 (2.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $203.83 | 52 Week High | $78.77 | |||
| Open | $204.81 | 52 Week Low | $55.00 | |||
| Day High | $211.80 | P/E | 72.20 | |||
| Day Low | $204.06 | EPS | $2.89 | |||
| Volume | 936,592 | |||||
